Literature DB >> 35420227

Whole-Abdomen Metabolic Imaging of Healthy Volunteers Using Hyperpolarized [1-13 C]pyruvate MRI.

Philip M Lee1,2, Hsin-Yu Chen2, Jeremy W Gordon2, Zhen J Wang2, Robert Bok2, Ralph Hashoian3, Yaewon Kim2, Xiaoxi Liu2, Tanner Nickles1,2, Kiersten Cheung2, Francesca De Las Alas2, Heather Daniel2, Peder E Z Larson1,2, Cornelius von Morze4, Daniel B Vigneron1,2, Michael A Ohliger2,5.   

Abstract

BACKGROUND: Hyperpolarized 13 C MRI quantitatively measures enzyme-catalyzed metabolism in cancer and metabolic diseases. Whole-abdomen imaging will permit dynamic metabolic imaging of several abdominal organs simultaneously in healthy and diseased subjects.
PURPOSE: Image hyperpolarized [1-13 C]pyruvate and products in the abdomens of healthy volunteers, overcoming challenges of motion, magnetic field variations, and spatial coverage. Compare hyperpolarized [1-13 C]pyruvate metabolism across abdominal organs of healthy volunteers. STUDY TYPE: Prospective technical development.
SUBJECTS: A total of 13 healthy volunteers (8 male), 21-64 years (median 36). FIELD STRENGTH/SEQUENCE: A 3 T. Proton: T1 -weighted spoiled gradient echo, T2 -weighted single-shot fast spin echo, multiecho fat/water imaging. Carbon-13: echo-planar spectroscopic imaging, metabolite-specific echo-planar imaging. ASSESSMENT: Transmit magnetic field was measured. Variations in main magnetic field (ΔB0 ) determined using multiecho proton acquisitions were compared to carbon-13 acquisitions. Changes in ΔB0 were measured after localized shimming. Improvements in metabolite signal-to-noise ratio were calculated. Whole-organ regions of interests were drawn over the liver, spleen, pancreas, and kidneys by a single investigator. Metabolite signals, time-to-peak, decay times, and mean first-order rate constants for pyruvate-to-lactate (kPL ) and alanine (kPA ) conversion were measured in each organ. STATISTICAL TESTS: Linear regression, one-sample Kolmogorov-Smirnov tests, paired t-tests, one-way ANOVA, Tukey's multiple comparisons tests. P ≤ 0.05 considered statistically significant.
RESULTS: Proton ΔB0 maps correlated with carbon-13 ΔB0 maps (slope = 0.93, y-intercept = -2.88, R2  = 0.73). Localized shimming resulted in mean frequency offset within ±25 Hz for all organs. Metabolite SNR significantly increased after denoising. Mean kPL and kPA were highest in liver, followed by pancreas, spleen, and kidneys (all comparisons with liver were significant). DATA
CONCLUSION: Whole-abdomen coverage with hyperpolarized carbon-13 MRI was feasible despite technical challenges. Multiecho gradient echo 1 H acquisitions accurately predicted chemical shifts observed using carbon-13 spectroscopy. Carbon-13 acquisitions benefited from local shimming. Metabolite energetics in the abdomen compiled for healthy volunteers can be used to design larger clinical trials in patients with metabolic diseases. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 1.
© 2022 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  [1-13C]pyruvate; abdomen; hyperpolarized MR; liver; metabolic imaging

Year:  2022        PMID: 35420227      PMCID: PMC9562149          DOI: 10.1002/jmri.28196

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   5.119


  37 in total

1.  B1 mapping by Bloch-Siegert shift.

Authors:  Laura I Sacolick; Florian Wiesinger; Ileana Hancu; Mika W Vogel
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

2.  Spectral-spatial excitation for rapid imaging of DNP compounds.

Authors:  Angus Z Lau; Albert P Chen; Ralph E Hurd; Charles H Cunningham
Journal:  NMR Biomed       Date:  2011-07-12       Impact factor: 4.044

3.  Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.

Authors:  Myriam M Chaumeil; Tomoko Ozawa; IlWoo Park; Kristen Scott; C David James; Sarah J Nelson; Sabrina M Ronen
Journal:  Neuroimage       Date:  2011-07-23       Impact factor: 6.556

4.  Denoising of hyperpolarized 13 C MR images of the human brain using patch-based higher-order singular value decomposition.

Authors:  Yaewon Kim; Hsin-Yu Chen; Adam W Autry; Javier Villanueva-Meyer; Susan M Chang; Yan Li; Peder E Z Larson; Jeffrey R Brender; Murali C Krishna; Duan Xu; Daniel B Vigneron; Jeremy W Gordon
Journal:  Magn Reson Med       Date:  2021-06-25       Impact factor: 4.668

5.  Timing of the hepatic arterial phase during contrast-enhanced computed tomography of the liver: assessment of normal values in 25 volunteers.

Authors:  T R Bader; R W Prokesch; F Grabenwöger
Journal:  Invest Radiol       Date:  2000-08       Impact factor: 6.016

6.  Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.

Authors:  Kayvan R Keshari; Renuka Sriram; Mark Van Criekinge; David M Wilson; Zhen J Wang; Daniel B Vigneron; Donna M Peehl; John Kurhanewicz
Journal:  Prostate       Date:  2013-03-26       Impact factor: 4.104

Review 7.  Hyperpolarized 13C MRI: State of the Art and Future Directions.

Authors:  Zhen J Wang; Michael A Ohliger; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; James Slater; Javier E Villanueva-Meyer; Christopher P Hess; John Kurhanewicz; Daniel B Vigneron
Journal:  Radiology       Date:  2019-03-05       Impact factor: 11.105

8.  Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients.

Authors:  Jeremy W Gordon; Hsin-Yu Chen; Adam Autry; Ilwoo Park; Mark Van Criekinge; Daniele Mammoli; Eugene Milshteyn; Robert Bok; Duan Xu; Yan Li; Rahul Aggarwal; Susan Chang; James B Slater; Marcus Ferrone; Sarah Nelson; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-10-30       Impact factor: 4.668

9.  Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer.

Authors:  Rahul Aggarwal; Daniel B Vigneron; John Kurhanewicz
Journal:  Eur Urol       Date:  2017-07-29       Impact factor: 20.096

10.  First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma.

Authors:  Maxine Tran; Arash Latifoltojar; Joana B Neves; Marianthi-Vasiliki Papoutsaki; Fiona Gong; Arnaud Comment; Ana S H Costa; Matthias Glaser; My-Anh Tran-Dang; Soha El Sheikh; Wivijin Piga; Alan Bainbridge; Anna Barnes; Tim Young; Hassan Jeraj; Ramla Awais; Sola Adeleke; Christopher Holt; James O'Callaghan; Frazer Twyman; David Atkinson; Christian Frezza; Erik Årstad; David Gadian; Mark Emberton; Shonit Punwani
Journal:  BJR Case Rep       Date:  2019-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.